SAN DIEGO, Oct. 1, 2019 /PRNewswire-PRWeb/ -- In advance of the 2020 launch of its novel system to reduce stethoscope
"Tom brings tremendous commercial expertise, passion, and demonstrated success in start-up device launches to the team," said Scott Mader, CEO and President of AseptiScope. "We remain extremely confident in our exceptional team as we introduce technology that will finally resolve an enormous patient safety concern."
"It's an exciting time to be part of AseptiScope and introducing a long-overdue solution to address a serious healthcare problem," said Tom Watlington. "We are taking meaningful steps toward the DiskCover System's launch, which will soon have a dramatic impact on reducing infectious disease transmissions and improving patient care."
About AseptiScope, Inc. AseptiScope is a privately funded San Diego, California based, clinical innovation company, formed in early 2016. The organization is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that ensure "Infection Protection for Clinician & Patient." The company will introduce the first true and practical solution for the longstanding challenge of stethoscope contamination in early 2020: The AseptiScope DiskCover™ System. Visit http://www.aseptiscope.com for more information.
SOURCE AseptiScope, Inc.